Lv11
50 积分 2024-11-15 加入
Corrigendum to “PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease” [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]
3小时前
已完结
The Biology and Clinical Implications of PCSK7
28天前
已完结
Surf4 regulates expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) but is not required for PCSK9 secretion in cultured human hepatocytes
1个月前
已完结
Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges
1个月前
已完结
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
1个月前
已完结
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
1个月前
已完结
Bile acid receptors as targets for drug development
1个月前
已完结
Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges
1个月前
已完结
Enhanced Oral Absorption and Liver Distribution of Polymeric Nanoparticles through Traveling the Enterohepatic Circulation Pathways of Bile Acid
1个月前
已完结
RNAi therapeutic and its innovative biotechnological evolution
1个月前
已完结
皖公网安备34019202002308
